Metabolic Disease CROs: Obesity, Diabetes and MASH Models

12 contract research organizations in our directory list Metabolic Disease Models as a capability, across 6 countries. 2 report GLP capability and 4 report AAALAC accreditation. Compare their species, services and accreditations below, and contact labs directly from their profiles.

12 CROs 2 GLP 4 AAALAC 6 countries

About Metabolic Disease Models

Metabolic disease programs, and especially incretin-based and other obesity drugs, have made in vivo metabolic pharmacology one of the busiest areas of preclinical outsourcing. The standard workhorse is the diet-induced obese (DIO) mouse, alongside genetic models such as ob/ob and db/db mice and the ZDF rat, and chemically induced models such as streptozotocin for insulin-deficient diabetes.

Typical endpoints include body weight and food intake, body composition by EchoMRI or DEXA, oral or intraperitoneal glucose and insulin tolerance tests, fasting insulin and lipids, and energy expenditure by indirect calorimetry. Hyperinsulinemic–euglycemic clamps measure insulin sensitivity directly but need surgical catheterization and experienced staff, so relatively few labs offer them.

For MASH (formerly NASH) and liver fibrosis, models range from dietary approaches such as high-fat, high-fructose and high-cholesterol diets to choline-deficient diets and toxin-induced fibrosis, read out by histological activity and fibrosis scoring. Some labs also run spontaneously obese and diabetic nonhuman primates when rodent pharmacology does not translate.

In vivo pharmacology CROs →

Metabolic Disease CROs: Obesity, Diabetes and MASH Models

Showing 12 CROs. Order rotates daily so no lab is permanently listed first.

The Jackson Laboratory (JAX In Vivo Services)

US

Nonprofit mouse genetics institute offering contract in vivo pharmacology using its own strains and humanized and PDX models across oncology, neuroscience, metabolism and immunology.

Metabolic Disease Models In Vivo Efficacy Neurodegenerative Models Oncology Models PDX Models Mouse

Oregon National Primate Research Center

US AAALAC

OHSU national primate research center supporting neuroscience, metabolic, reproductive and infectious disease research, with core services available to outside investigators.

Metabolic Disease Models CNS Disease Models In Vivo Efficacy Infectious Disease Models Non-human Primate Rhesus monkey

Sygnature Discovery

GB

Integrated drug discovery CRO in Nottingham with in vivo pharmacology, DMPK and bioanalysis alongside chemistry and biology.

Metabolic Disease Models In Vitro ADME In Vivo Efficacy In Vivo PK Inflammation Models Mouse Rat

Melior Discovery

US

In vivo pharmacology CRO near Philadelphia running a broad catalog of efficacy models across CNS, pain, metabolic and inflammatory disease.

Metabolic Disease Models CNS Disease Models In Vivo Efficacy Inflammation Models Pain Models Mouse Rat

Physiogenex

FR

Preclinical CRO near Toulouse specializing in metabolic disease pharmacology, including obesity, diabetes and NASH/MASH models.

Metabolic Disease Models Hepatic Disease Models In Vivo Efficacy Mouse Rat

SMC Laboratories

JP

Tokyo CRO known for NASH/MASH and fibrosis mouse models, with efficacy studies across liver, kidney and metabolic disease.

Metabolic Disease Models Hepatic Disease Models In Vivo Efficacy Renal Disease Models Mouse

GemPharmatech

CN

Chinese provider of genetically engineered mouse models with in vivo pharmacology services across oncology, immunology and metabolic disease.

Metabolic Disease Models In Vivo Efficacy Oncology Models PDX Models Mouse

Shanghai Model Organisms Center (SMOC)

CN

Shanghai provider of genetically engineered rodent models with phenotyping and in vivo pharmacology services.

Metabolic Disease Models In Vivo Efficacy Oncology Models Mouse Rat

Virscio

US GLP AAALAC

Translational research company using Old World primate models for ophthalmology, CNS and metabolic disease studies, with an AAALAC-accredited primate facility.

Metabolic Disease Models CNS Disease Models In Vivo Efficacy Ophthalmology Models Pharmacokinetics Non-human Primate

Hamamatsu Pharma Research

JP AAALAC

AAALAC-accredited Japanese CRO specializing in nonhuman primate disease models for preclinical efficacy and proof of concept.

Metabolic Disease Models CNS Disease Models In Vivo Efficacy Non-human Primate

PharmaLegacy Laboratories

CN GLP AAALAC

Preclinical pharmacology CRO in Shanghai with specialty efficacy models in autoimmunity, inflammation, bone and orthopedics, oncology and metabolic disease, plus supporting PK/PD and exploratory toxicology.

Metabolic Disease Models Bone & Joint Models In Vivo Efficacy Inflammation Models Oncology Models Dog Mouse Non-human Primate Rabbit

Gubra

DK

Danish preclinical CRO and peptide discovery company known for metabolic, liver and kidney disease models with AI-supported histology and 3D imaging readouts.

Metabolic Disease Models Hepatic Disease Models Histopathology In Vivo Efficacy Renal Disease Models Mouse Rat

Questions to ask when choosing a Metabolic Disease Models CRO

  • Which metabolic models do you run in-house, and what diet, vendor and age at start do you use for DIO animals?
  • What positive control do you use (for example a GLP-1 receptor agonist), and what effect size do you typically see?
  • Do you measure body composition, food intake and energy expenditure in the same animals?
  • Do you offer hyperinsulinemic–euglycemic clamps, and in which species?
  • For MASH studies, who scores liver histology, is it blinded, and which scoring system is used?